Lexpos News

/Lexpos News/

Prime Minister speaks positively about Community Pharmacy during PMQs

The Prime Minister was asked at PMQs today what the Government is doing to improve access to General Practice. In his answer, Sir Keir Starmer said: “We are going to expand the role of community pharmacies and accelerate the roll-out of independent prescribing. We need much more care to be delivered in local communities to [...]

The post Prime Minister speaks positively about Community Pharmacy during PMQs appeared first on Community Pharmacy England.

By |October 9th, 2024|Lexpos News|Comments Off on Prime Minister speaks positively about Community Pharmacy during PMQs

Economic analysis: How much does it cost to run a pharmacy?

Community pharmacy owners are invited to share data to inform an important fiscal review of the sector. Frontier Economics and IQVIA have been commissioned to carry out an economic analysis of community pharmacy on behalf of NHS England. This includes understanding the full economic costs of delivering NHS pharmaceutical services and how these costs vary, [...]

The post Economic analysis: How much does it cost to run a pharmacy? appeared first on Community Pharmacy England.

By |October 9th, 2024|Lexpos News|Comments Off on Economic analysis: How much does it cost to run a pharmacy?

Medicine Supply Notification: Trandate® (labetalol) 50mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Trandate® (labetalol) 50mg tablets MSN/2024/101 Tier 2 medium impact Date of issue: 7th October 2024 Trandate® (labetalol) 50mg tablets will be discontinued from July 2025. Alternative low dose beta-blockers remain available. Where these are not suitable, UK manufactured Specials of labetalol [...]

The post Medicine Supply Notification: Trandate® (labetalol) 50mg tablets appeared first on Community Pharmacy England.

By |October 7th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Trandate® (labetalol) 50mg tablets

MHRA Class 3 Medicines Recall: Trandolapril 2mg and 4mg capsules (Viatris UK Healthcare Ltd)

MHRA Class 3 Medicines Recall: Trandolapril 2mg and 4mg capsules (Viatris UK Healthcare Ltd) Drug alert number: EL(24)A/47 Date issued: 07 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a Class 3 medicines defect information notice for: Trandolapril 2mg and 4mg capsules (Viatris UK Healthcare Ltd) Company name: Viatris UK Healthcare [...]

The post MHRA Class 3 Medicines Recall: Trandolapril 2mg and 4mg capsules (Viatris UK Healthcare Ltd) appeared first on Community Pharmacy England.

By |October 7th, 2024|Lexpos News, mhra|Comments Off on MHRA Class 3 Medicines Recall: Trandolapril 2mg and 4mg capsules (Viatris UK Healthcare Ltd)

LPC Chairs Forum convened to advise Community Pharmacy England

A Forum of LPC Chairs, created to provide more local input into the representation of pharmacy owners at a national level, met for the first time last week. The new Forum aims to bring a stronger local voice to national work, steer Community Pharmacy England on local matters, and foster collaboration on areas of mutual [...]

The post LPC Chairs Forum convened to advise Community Pharmacy England appeared first on Community Pharmacy England.

By |October 4th, 2024|Lexpos News|Comments Off on LPC Chairs Forum convened to advise Community Pharmacy England